DC
MACK

Deere & Company’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Deere & Company’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,723
Closed -$169K – 1301
2015
Q4 		$169K Hold
2,723
– – 0.01% 872
2015
Q3 		$182K Buy
+2,723
New +$222K 0.01% 868

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Deere & Company's MACK Position: Q1 2016 in Review

Deere & Company sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q1 2016, closing a stake of 2,723 shares — an estimated $169K sold.

Deere & Company first reported a position in MACK in Q3 2015 and held it in 2 quarters. The position peaked at $182K in Q3 2015. 139 funds tracked by Wall St. Rank hold MACK as of Q1 2016.

  • Deere & Company reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Deere & Company sold 2,723 Merrimack Pharmaceuticals, Inc. shares in Q1 2016, an estimated $169K.
  • Deere & Company first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2015 and held it in 2 quarters.
  • Deere & Company's Merrimack Pharmaceuticals, Inc. position peaked at $182K in Q3 2015.
  • 139 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.